|
|
Congress Program : Plenary Sessions and SymposiaSunday, April 22, 10.00 – 10.30 New York Marriott Marquis Hotel, Opening Ceremony
Sunday, April 22, 10.30 – 11.15 New York Marriott Marquis Hotel, ALAIN D'WECK HONORARY LECTURE
New York Marriott Marquis Hotel, ALBERT OEHLING HONORARY LECTURE
Walter Canonica Genoa, Italy The future of asthma treatments: from blockbusters to biosimilars
Sunday, April 22, 12.30 – 14.30 New York Marriott Marquis Hotel, Plenary Session
Nikolai Khaltaev Geneva, Switzerland WHO/GARD strategy for the prevention and control of chronic respiratory diseases Clive Page London, U.K. PDE inhibitors in the treatment of Asthma and COPD Adnan Custovic Manchester, UK Asthma: Nature or nurture Paul A. Greenberger Chicago, USA Difficult respiratory phenotypes in adults with asthma Carlos E. Baena-Cagnani Cordoba, Argentina Phenotype in severe asthma in children Benjamin Volovitz Petah Tiqva, Israel New insights in the management of acute asthma exacerbation in young children
Sunday, April 22, 15.30 – 18.00 New York Marriott Marquis Hotel, Plenary Session
Adnan Custovic Manchester, UK How many diseases are there in asthma? Allen Kaplan Charleston, USA Endothelial cells and the inflammatory response G. Walter Canonica Genoa, Italy Allergen specific immunotherapy in asthma treatment Sergio Bonini Rome, Italy Regulatory aspects of allergen specific immunotherapy Ruby Pawankar Tokyo, Japan IgE-immune cell interactions in allergic disease: clinical implications and therapeutic directions Lawrence DuBuske Gardner, USA Toll like receptor modulation of allergen immunotherapy
Monday, April 23, 09.30 – 10.30 New York Marriott Marquis Hotel, Plenary Session
Ronald Dahl Arthus, The Netherlands Asthma exacerbations Lanny Rosenwasser Kansas City, USA Biologic response modified in allergic diseases Rudolf Valenta Vienna, Austria New developments in recombinant allergen-based immunotherapy
Monday, April 23, 10.30 – 11.00 New York Marriott Marquis Hotel, WAO Presidential Lecture
Ruby Pawankar Tokyo, Japan Allergy a global health problem: The WAO White Book on Allergy
Monday, April 23, 11.00 – 12.00 New York Marriott Marquis Hotel, Plenary Session
Sami Bahna Shreveport, USA How does eNO measurement fit in asthma assessment? Allen Kaplan Charleston, USA A link between mast cell activation and bradykinin formation Sergio Bonini Rome, Italy Clinical trials for registering new anti-allergic drugs
Monday, April 23, 12.30 – 14.30 New York Marriott Marquis Hotel, Plenary Session
Rudolf Valenta Vienna, Austria Therapeutic targeting of IgE Ignacio Ansotegui Erandio, Bilbao, Spain Update on allergy diagnosis Ronald Dahl Arthus, The Netherlands Asthma treatment with 'temperature regulated laminar airflow' Paul A. Greenberger Chicago, USA Achieving control of fungal asthma and allergic bronchopulmonary mycosis Carlos Nunes Portimao, Portugal Swimming and asthma: myth and evidence
Monday, April 23, 15.30 – 17.15 New York Marriott Marquis Hotel, Symposium
Lawrence DuBuske Gardner, USA Biologicals for severe asthma Gennaro D’Amato Naples, Italy Social networks and bronchial asthma Carlos Nunes Portimao, Portugal Economic impact of rhinitis and asthma Todor Popov Sofia, Bulgaria Airway inflammation in smokers: peculiarities of asthma diagnosis and treatment
Monday, April 23, 17.20 – 19.00 New York Marriott Marquis Hotel, Symposium
Kristóf Nékám Budapest, Hungary The clinical relevance and societal burden of geronto-immuno-allergies Kamal Maurice Hanna Cairo, Egypt Complementary and alternative medicine for respiratory diseases: an update Bogdan Petrunov Sofia, Bulgaria Allergen specific immunotherapy of respiratory allergic diseases – clinical and immunological changes Nikolai Khaltaev Geneva, Switzerland Diet and chronic respiratory diseases
Tuesday, April 24, 10.00 – 12.00 New York Marriott Marquis Hotel, Plenary Session
Carlos E. Baena-Cagnani Cordoba, Argentina Asthma in children: from early symptoms to asthma in adults Samuel Lin, Danielle Casanova, Joyce Jones, Julie Sanderson-Austin, Donald Fisher Alexandria, Virginia, USA Case studies of practical, patient-centered, parsimonious initiatives that significantly improve the care and quality of life for patients with COPD Gennaro D’Amato Naples, Italy Update on climate change, extreme events and respiratory allergy Ignacio Ansotegui Erandio, Bilbao, Spain Air pollution, climate change and hygiene hypothesis Antero Palma-Carlos Lisbon, Portugal Bacterial immunomodulators in asthma, COPD and recurrent respiratory infections Bogdan Petrunov Sofia, Bulgaria The role of fungal allergens in respiratory diseases in Bulgaria
Tuesday, April 24, 12.30 – 15.00 New York Marriott Marquis Hotel, Symposium
Elias Toubi Haifa, Israel Immunoregulatory mechanisms in asthma Antero Palma-Carlos Lisbon, Portugal Protease inhibitors asthma and rhinosinusitis Todor Popov Sofia, Bulgaria Symptoms of Nasal Inconvenience Fact Finding (SNIFF) project in Bulgaria Kristóf Nékám Budapest, Hungary From sick building to sick residents - causes of and solutions for low indoor air quality S. Eyers, K. Perrin, M. Weatherall, R. Siebers, J. Crane, J. Travers, P. Shirtcliffe, R. Beasley Wellington, New Zealand A randomised controlled trial of the effect of regular paracetamol (acetaminophen) on airway responsiveness and asthma control
Tuesday, April 24, 15.00 – 15.30 New York Marriott Marquis Hotel, ClosinG Ceremony
Handling of Awards
WORLD IMMUNOPATHOLOGY ORGANIZATION E-mail: info@wipocis.org |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||